![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07H 7/04 | |
A61K 31/70 | |||
A61P 3/10 |
(11) | Number of the document | 2991999 |
(13) | Kind of document | T |
(96) | European patent application number | 13883354.6 |
Date of filing the European patent application | 2013-12-23 | |
(97) | Date of publication of the European application | 2016-03-09 |
(45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IL2013/051048 |
Date | 2013-12-23 |
(87) | Number | WO 2014/178040 |
Date | 2014-11-06 |
(30) | Number | Date | Country code |
201361816809 P | 2013-04-29 | US |
(72) |
MAROM, Ehud, IL
RUBNOV, Shai, IL
|
(73) |
Mapi Pharma Limited,
16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona,
IL
|
(54) | DAPAGLIFLOZIN LACTOSE CO-CRYSTAL |
DAPAGLIFLOZIN LACTOSE CO-CRYSTAL |